Blaise A Coleman
Chief Executive Officer chez ENDO INTERNATIONAL PLC
Fortune : 169 $ au 31/03/2024
Profil
Blaise A Coleman is currently the President, Chief Executive Officer & Director at Endo International Plc.
Previously, he held positions as the Chairman, President & Chief Executive Officer at BioSpecifics Technologies Corp.
and as the Senior Director-Commercial Finance at AstraZeneca US Investments Ltd.
He also served as the Chief Financial Officer at AstraZeneca AB from 2013 to 2015.
Mr. Coleman completed his undergraduate degree at Widener University and earned an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENDO INTERNATIONAL PLC
0,18% | 12/04/2023 | 422 066 ( 0,18% ) | 169 $ | 31/03/2024 |
Postes actifs de Blaise A Coleman
| Sociétés | Poste | Début |
|---|---|---|
| ENDO INTERNATIONAL PLC | Chief Executive Officer | 06/03/2020 |
Anciens postes connus de Blaise A Coleman
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Director of Finance/CFO | 01/01/2015 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Chief Executive Officer | - |
AstraZeneca US Investments Ltd.
 AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK and was founded in 2002. | Corporate Officer/Principal | - |
Formation de Blaise A Coleman
| Widener University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENDO INTERNATIONAL PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
AstraZeneca US Investments Ltd.
AstraZeneca US Investments Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The private company is based in Cambridge, UK and was founded in 2002. | Finance |
